Sano T, Hollowood A
Gastric Surgery Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Scand J Surg. 2006;95(4):249-55. doi: 10.1177/145749690609500407.
The prognosis of early gastric cancer (EGC) is excellent worldwide. Incidence of EGC shows considerable geographic variation, and in high prevalence areas where diagnostic skills are adept, EGCs are not frequently overlooked. In these countries, less invasive, function-preserving treatments such as endoscopic mucosal resection and pylorus-preserving gastrectomy have become standard options. The criteria to apply conservative treatments are being expanded along with the technological improvement. Though its natural history is relatively long, EGC could be a fatal disease and should be carefully treated. Lymph node metastasis is the most important prognostic factor that should be considered in treatment selection and follow-up planning of EGC.
早期胃癌(EGC)在全球范围内的预后良好。EGC的发病率存在显著的地域差异,在诊断技术娴熟的高发病地区,EGC并不常被漏诊。在这些国家,诸如内镜黏膜切除术和保留幽门的胃切除术等侵入性较小、保留功能的治疗方法已成为标准选择。随着技术的进步,应用保守治疗的标准也在不断扩大。尽管EGC的自然病程相对较长,但它可能是一种致命疾病,应予以谨慎治疗。淋巴结转移是EGC治疗选择和随访计划中应考虑的最重要的预后因素。